Saxagliptin Add-on Therapy to Insulin With or Without Metformin for Type 2 Diabetes Mellitus: 52-Week Safety and Efficacy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Saxagliptin Add-on Therapy to Insulin With or Without Metformin for Type 2 Diabetes Mellitus: 52-Week Safety and Efficacy
Authors
Keywords
Metformin, Hypoglycemia, Vildagliptin, Saxagliptin, Total Daily Dose
Journal
CLINICAL DRUG INVESTIGATION
Volume 33, Issue 10, Pages 707-717
Publisher
Springer Nature
Online
2013-08-14
DOI
10.1007/s40261-013-0107-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control
- (2013) Helena Rodbard et al. Endocrine Practice
- Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin
- (2012) Anthony H. Barnett et al. CURRENT MEDICAL RESEARCH AND OPINION
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Influence of preprandial vs. postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096)
- (2011) R. Ratner et al. DIABETES OBESITY & METABOLISM
- Advantages of Extended-Release Metformin in Patients with Type 2 Diabetes Mellitus
- (2011) Serge Jabbour et al. POSTGRADUATE MEDICINE
- Saxagliptin: A dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
- (2010) J. J. Neumiller et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Pharmacological management of type 2 diabetes: the potential of incretin-based therapies
- (2010) B. Charbonnel et al. DIABETES OBESITY & METABOLISM
- A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study
- (2010) J. Gordon et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes
- (2010) A. H. Barnett et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A Physiologic and Pharmacological Basis for Implementation of Incretin Hormones in the Treatment of Type 2 Diabetes Mellitus
- (2010) Jeffrey S. Freeman MAYO CLINIC PROCEEDINGS
- Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1cwithout causing weight gain or increased hypoglycaemia
- (2009) J. Rosenstock et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
- (2009) T. Vilsbøll et al. DIABETES OBESITY & METABOLISM
- Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes
- (2009) Aruna D. Pradhan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sustained Efficacy and Reduced Hypoglycemia during One Year of Treatment with Vildagliptin Added to Insulin in Patients with Type 2 Diabetes Mellitus
- (2008) V. Fonseca et al. HORMONE AND METABOLIC RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started